IHC profiling showed that PIM-1 was primarily localized in cancer cells and tended to be weakly expressed in untreated CNPC, whereas it was moderately but constitutively expressed in CRPC and apalutamide-treated CNPC (Figure 7F). This evidence concerns the gene PIM1 and cancer.